Literature DB >> 9677338

ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

N J Hellyer1, K Cheng, J G Koland.   

Abstract

ErbB3 (HER3), a unique member of the ErbB receptor family, lacks intrinsic protein tyrosine kinase activity and contains six Tyr-Xaa-Xaa-Met (YXXM) consensus binding sites for the SH2 domains of the p85 regulatory subunit of phosphoinositide 3-kinase. ErbB3 also has a proline-rich sequence that forms a consensus binding site for the SH3 domain of p85. Here we have investigated the interacting domains of ErbB3 and p85 by a unique application of the yeast two-hybrid system. A chimaeric ErbB3 molecule containing the epidermal growth factor receptor protein tyrosine kinase domain was developed so that the C-terminal domain of ErbB3 could become phosphorylated in the yeast system. We also generated several ErbB3 deletion and Tyr-->Phe site-specific mutants, and observed that a single ErbB3 YXXM motif was necessary and sufficient for the association of ErbB3 with p85. The incorporation of multiple YXXM motifs into the ErbB3 C-terminus enabled a stronger ErbB3/p85 interaction. The proline-rich region of ErbB3 was not necessary for interaction with p85. However, either deletion or mutation of the p85 SH3 domain decreased the observed ErbB3/p85 association. Additionally an ErbB3/p85 SH3 domain interaction was detected by an assay in vitro. These results were consistent with a model in which pairs of phosphorylated ErbB3 YXXM motifs co-operate in binding to the tandem SH2 domains of p85. Although a contributing role for the p85 SH3 domain was suggested, the N- and C-terminal SH2 domains seemed to be primarily responsible for the high-affinity association of p85 and ErbB3.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9677338      PMCID: PMC1219642          DOI: 10.1042/bj3330757

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  Solution structure of the SH3 domain of Src and identification of its ligand-binding site.

Authors:  H Yu; M K Rosen; T B Shin; C Seidel-Dugan; J S Brugge; S L Schreiber
Journal:  Science       Date:  1992-12-04       Impact factor: 47.728

2.  SH2 domains of the p85 alpha subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors.

Authors:  C J McGlade; C Ellis; M Reedijk; D Anderson; G Mbamalu; A D Reith; G Panayotou; P End; A Bernstein; A Kazlauskas
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

Review 3.  Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis.

Authors:  S Burden; Y Yarden
Journal:  Neuron       Date:  1997-06       Impact factor: 17.173

4.  Synthesis of epidermal growth factor (EGF) receptor in vitro using SP6 RNA polymerase-transcribed template mRNA.

Authors:  A J Clark; L Beguinot; S Ishii; D P Ma; B A Roe; G T Merlino; I Pastan
Journal:  Biochim Biophys Acta       Date:  1986-08-22

5.  Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein.

Authors:  S L Sierke; K Cheng; H H Kim; J G Koland
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

6.  Structural organization of the bcr gene and its role in the Ph' translocation.

Authors:  N Heisterkamp; K Stam; J Groffen; A de Klein; G Grosveld
Journal:  Nature       Date:  1985 Jun 27-Jul 3       Impact factor: 49.962

7.  Expression of epidermal growth factor receptor sequences as E. coli fusion proteins: applications in the study of tyrosine kinase function.

Authors:  J G Koland; K M O'Brien; R A Cerione
Journal:  Biochem Biophys Res Commun       Date:  1990-01-15       Impact factor: 3.575

8.  Tandem SH2 domains confer high specificity in tyrosine kinase signaling.

Authors:  E A Ottinger; M C Botfield; S E Shoelson
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

9.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

10.  Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor.

Authors:  W S Chen; C S Lazar; M Poenie; R Y Tsien; G N Gill; M G Rosenfeld
Journal:  Nature       Date:  1987 Aug 27-Sep 2       Impact factor: 49.962

View more
  62 in total

1.  ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma.

Authors:  J Spencer Liles; Juan Pablo Arnoletti; Ching-Wei D Tzeng; J Harrison Howard; Andrew V Kossenkov; Peter Kulesza; Martin J Heslin; Andrey Frolov
Journal:  Cancer Biol Ther       Date:  2010-09-30       Impact factor: 4.742

2.  ErbB3 downregulation enhances luminal breast tumor response to antiestrogens.

Authors:  Meghan M Morrison; Katherine Hutchinson; Michelle M Williams; Jamie C Stanford; Justin M Balko; Christian Young; Maria G Kuba; Violeta Sánchez; Andrew J Williams; Donna J Hicks; Carlos L Arteaga; Aleix Prat; Charles M Perou; H Shelton Earp; Suleiman Massarweh; Rebecca S Cook
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

3.  TLR4/MyD88/PI3K interactions regulate TLR4 signaling.

Authors:  Michelle H W Laird; Sang Hoon Rhee; Darren J Perkins; Andrei E Medvedev; Wenji Piao; Matthew J Fenton; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2009-03-16       Impact factor: 4.962

4.  PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance.

Authors:  Howard M Stern; Humphrey Gardner; Tomasz Burzykowski; Wafaa Elatre; Carol O'Brien; Mark R Lackner; Gary A Pestano; Angela Santiago; Ivonne Villalobos; Wolfgang Eiermann; Tadeusz Pienkowski; Miguel Martin; Nicholas Robert; John Crown; Paolo Nuciforo; Valerie Bee; John Mackey; Dennis J Slamon; Michael F Press
Journal:  Clin Cancer Res       Date:  2015-02-03       Impact factor: 12.531

5.  The diacylglycerol kinase α (DGKα)/Akt/NF-κB feedforward loop promotes esophageal squamous cell carcinoma (ESCC) progression via FAK-dependent and FAK-independent manner.

Authors:  Jie Chen; Weimin Zhang; Yan Wang; Di Zhao; Mengjiao Wu; Jiawen Fan; Jinting Li; Ying Gong; Nana Dan; Di Yang; Rui Liu; Qimin Zhan
Journal:  Oncogene       Date:  2018-12-07       Impact factor: 9.867

6.  Neuregulin-1 enhances survival of human astrocytic glioma cells.

Authors:  Patricia S Ritch; Steven L Carroll; Harald Sontheimer
Journal:  Glia       Date:  2005-08-15       Impact factor: 7.452

Review 7.  The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies.

Authors:  Anne W Hamburger
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-04-19       Impact factor: 2.673

Review 8.  Clinical significance of the integrin α6β4 in human malignancies.

Authors:  Rachel L Stewart; Kathleen L O'Connor
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

9.  Oscillatory flow-induced proliferation of osteoblast-like cells is mediated by alphavbeta3 and beta1 integrins through synergistic interactions of focal adhesion kinase and Shc with phosphatidylinositol 3-kinase and the Akt/mTOR/p70S6K pathway.

Authors:  Ding-Yu Lee; Yi-Shuan J Li; Shun-Fu Chang; Jing Zhou; Hui-Min Ho; Jeng-Jiann Chiu; Shu Chien
Journal:  J Biol Chem       Date:  2009-11-04       Impact factor: 5.157

10.  Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium.

Authors:  Daekee Lee; Ming Yu; Eunjung Lee; Hyunok Kim; Yanan Yang; Kyoungmi Kim; Christina Pannicia; Jonathan M Kurie; David W Threadgill
Journal:  J Clin Invest       Date:  2009-08-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.